Truist Securities Maintains Buy on Merck & Co, Raises Price Target to $139-Report Released on 1 February 2024
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Robyn Karnauskas maintains a Buy rating on Merck & Co (MRK) and raises the price target from $122 to $139 as of 1 February 2024.
February 02, 2024 | 7:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has maintained a Buy rating on Merck & Co and increased the price target from $122 to $139.
The increase in the price target by Truist Securities reflects a positive outlook on Merck & Co's future performance. This endorsement from a reputable analyst is likely to instill confidence in investors, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100